PharmX Ltd, a growing pharmaceutical and life sciences firm launches a new healthcare product. This product always requires a precise temperature of 40 degrees Celsius to operate effectively.

PharmX Ltd approaches Heatec Ltd, a manufacturer of high-end heating and temperature devices. PharmX Ltd communicates the precise reason for purchasing such High-end heating device and asks for devices capable of reaching a temperature of 40 degrees Celsius.

Heatec Ltd promises to deliver the appropriate equipment based on the criteria shared by PharmX Ltd. Upon delivery, it is discovered that the device does not provide adequate temperature or heating. Indeed, the maximum temperature it can generate is 32 degrees Celsius. As a result, PharmX products have underperformed, and its clients are calling for refunds.

Advise PharmX Ltd of any potential claims under the Sale of Goods Act 1979.